Literature DB >> 11437489

A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions.

T Olivry1, S M Dunston, M Schachter, L Xu, N Nguyen, M P Marinkovich, L S Chan.   

Abstract

Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering dermatosis of humans that was previously known as cicatricial pemphigoid. It is characterized by vesicles, ulcers and scarring that affect predominantly mucosae and mucocutaneous junctions. Circulating autoantibodies recognize epitopes on basement membrane proteins such as collagen XVII or laminin-5/6. Herein, we describe the clinico-pathological and immunological characteristics of 17 dogs afflicted with a dermatosis homologous to MMP of humans. Patients exhibited vesicles and erosions predominantly on mucous membranes or mucocutaneous junctions of the mouth, nose, eyes, genitalia or anus. Histopathology revealed subepithelial vesicles with variable dermal inflammation. Direct immunofluorescence demonstrated IgG or complement at the dermoepithelial junction. Indirect immunofluorescence using salt-split epithelia permitted the detection of circulating basement membrane-specific IgG autoantibodies in 15 cases. In 11 patients, autoantibodies recognized the NC16A segment of collagen XVII, as determined by salt-split indirect immunofluorescence, immunoblotting using canine keratinocytes and ELISA with synthetic canine peptides. In one dog, autoantiodies bound to the dermal side of salt-split epithelia and recognized epitopes within the 30 kDa carboxy-terminal segment of human collagen XVII. Canine MMP, like its human counterpart, exhibits distinctive clinical signs and histopathological lesions, yet circulating autoantibodies target different antigenic epitopes. This spontaneous canine model of MMP could prove useful for studies on the pathogenesis or therapy of this human disease. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11437489     DOI: 10.1006/jaut.2001.0510

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].

Authors:  I Elser; D Selimovic; T Ruzicka; A Kuhn; M Megahed
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Putative contact ketoconazole shampoo-triggered pemphigus foliaceus in a dog.

Authors:  Hyun-Jeong Sung; In-Hwa Yoon; Jung-Hyun Kim
Journal:  Can Vet J       Date:  2017-09       Impact factor: 1.008

3.  Effect of substrate selection on indirect immunofluorescence testing of canine autoimmune subepidermal blistering diseases.

Authors:  C Favrot; S Dunston; J Deslandes; M Paradis; T Olivry
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

4.  Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus.

Authors:  Jae-Eun Hyun; Yeong-Hun Kang; Cheol-Yong Hwang
Journal:  Vet Sci       Date:  2021-04-23

5.  Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases.

Authors:  Masha Fridkis-Hareli
Journal:  J Autoimmune Dis       Date:  2008-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.